Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IBB

Recent news which mentions IBB

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Tickers ADPT AFIB ANVS ATHX
Tags CMPI KDMN RGNX
From Benzinga
The anti-Cathie Wood ETF has landed. Here’s how it’s doing so far
Tickers AAPL AMZN ARKF ARKG
Tags SARK GS UK:GLEN
From MarketWatch
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
Tickers APTO APYX BIIB BLFS
Tags APTO GMDA NPCE
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Tickers ACIU ADMA AFMD AMPE
Tags ACIU LIFE Offerings
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Tickers ACHV ACIU AEMD AGEN
Tags BIIB Offerings Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Tickers ABUS ACAD ACIU ADAP
Tags NXTC Market News EDIT
From Benzinga
Pfizer’s COVID-19 Pill Has Mixed Results for Healthcare ETFs
Tickers BBH IBB IHE
Tags Sector ETFs iShares Invesco
From ETF Trends
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Tickers ACXP ASRT AXNX CALA
Tags MRUS CALA IPOs
From Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Tickers AERI ALGS ALLO ANIP
Tags TALS AERI ARNA
From Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Tickers ADPT AGIO AMRN AMRX
Tags News UTHR PEN
From Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
Tickers AADI AMYT BMRN BYSI
Tags Benzinga AMYT OYST
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Tickers AADI AMGN AVNS CNTX
Tags Benzinga ESPR LLY
From Benzinga
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
Tickers BBH BNTX FEVR GERM
Tags NASDAQ:NVAX,NASDAQ:BNTX,NASDAQ:MRNA,NYSE:MRK,NYSEARCA:GERM,NYSEARCA:FEVR,NASDAQ:IBB,NASDAQ:BBH NVAX Stocks to Buy
From InvestorPlace
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Tickers ADPT AERI AGIO ALGS
Tags ESPR PBYI Benzinga
From Benzinga
Biotech Ready to Participate in Healthcare Bullishness
Tickers BBC BBH IBB SBIO
Tags ETF Building Blocks Channel BlackRock IBB
From ETF Trends
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
Tickers A ABBV ABIO ANIP
Tags PFE RMD LMAT
From Benzinga
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Tickers ALDX ALIM ALNY BAX
Tags HCWB BPMC FDA
From Benzinga
Fund managers are tossing out their losers. Here are the bargains investors might not want to miss.
Tickers AAPL CAT COMP DASH
Tags BX:TMUBMUSD10Y MA MRK
From MarketWatch
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
Tickers ANAB AZN AZYO BNTX
Tags AZN Benzinga LLY
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Tickers ABBV ADAP ALIM ALKS
Tags Earnings TMO BNTX
From Benzinga
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
Tickers ADPT ATHA AVRO IBB
Tags MRNA Market News IPOs
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
Tickers ABEO ADMA BHC BMY
Tags PSTV ABEO Offerings
From Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
Tickers ABT AKRO BIIB DTIL
Tags IPOs Market News ABT
From Benzinga
The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio
Tickers BMY BNTX CALA CELC
Tags PBYI Benzinga TAK
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
Tickers ABEO ABT AVDL AVRO
Tags SNGX ABEO PSTV
From Benzinga
2 Tricks and a Treat for Gene Therapy Investors
Tickers ALPMF BLUE CRSP EDIT
Tags Market News BLUE GILD
From Motley Fool
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
Tickers AMTI AVDL AZN BAYRY
Tags AVDL Biotech FDA
From Benzinga
Legend Biotech Hits New 54-Week High
Tickers CNCR IBB SBIO
Tags ALPS CNCR SBIO
From ETF Trends
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
Tickers ATRA CRSP CTSO FIXX
Tags SYNH STIM FDA
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Tickers ABSI ADMA ADXN AERI
Tags GKOS ADXN PTPI
From Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.